Final clinical results and first translational correlates of a phase 2 trial of adaptively dosed nivolumab and ipilimumab based on early radiographic assessment in advanced melanoma (ADAPT-IT).-MedSci.cn

Final clinical results and first translational correlates of a phase 2 trial of adaptively dosed nivolumab and ipilimumab based on early radiographic assessment in advanced melanoma (ADAPT-IT).

Smithy, JW; Kalvin, HL; Raber, V; Maher, CA; Kleman, J; McIntyre, DAG; Shoushtari, AN; Warner, AB; Callahan, MK; Momtaz, P; Eton, O; Nair, S; Wolchok, JD; Chapman, PB; Panageas, K; Postow, MA

JOURNAL OF CLINICAL ONCOLOGY, 2023; 41 (16):

科室
- - 订阅+
  - 更多科室
工具
服务